← All Sponsors
SPONSOR

University of Maryland, Baltimore

Total Trials
15
Recruiting
15
Phases
Phase 1, Phase 2, Phase 2, Phase 4, EARLY_Phase 1

University of Maryland, Baltimore is a clinical research sponsor with 15 registered studies on ClinicalTrials.gov, of which 15 are actively recruiting participants. Research covers conditions including Sickle Cell Disease, Sepsis, Patient Deterioration, Image.

The trial portfolio spans Phase 1, Phase 2, Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Maryland, Baltimore

How many clinical trials has University of Maryland, Baltimore sponsored?
ClinicalMetric currently tracks 15 clinical trials sponsored by University of Maryland, Baltimore, of which 15 are actively recruiting participants. These trials cover conditions including Sickle Cell Disease, Sepsis, Patient Deterioration. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Maryland, Baltimore research focus on?
University of Maryland, Baltimore clinical trials span Sickle Cell Disease, Sepsis, Patient Deterioration, Image, Warburg Effect, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Maryland, Baltimore clinical trial?
To participate in a University of Maryland, Baltimore trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Maryland, Baltimore trials with current recruitment status updated daily.

Clinical Trials by University of Maryland, Baltimore

NCT07674277
Recruiting

Virtual Reality for SCD VOC

Sickle Cell Disease
NCT06779617
Recruiting

UMMS Sepsis Early Prediction Score (SEPSys) and RESCUE Score Combined Clinical Trial

Sepsis
NCT05697406 Phase 1, Phase 2
Recruiting

HP Pyruvate MRI in Cancers

Image
NCT05223803 Phase 2
Recruiting

TERPS Trial for de Novo Oligometastic Prostate Cancer

Prostate Cancer
NCT06501781
Recruiting

Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)

HIV Infections
NCT03971669 Phase 4
Recruiting

Blood Donor CVD 5000

Risk Reduction
NCT06199154 EARLY_Phase 1
Recruiting

Induction of Labor in Morbidly Obese Patients

Morbid Obesity
NCT03201094
Recruiting

Impact of NMES and HPRO on Recovery After SAH- Pilot Study

Subarachnoid Hemorrhage
NCT04550728 Phase 1, Phase 2
Recruiting

Hybrid Robot+FES Stroke Rehabilitation

Stroke
NCT07378800
Recruiting

Fostering Positive Care Interactions in Assisted Living

Dementia
NCT06993597
Recruiting

Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy

Glaucoma
NCT06155682
Recruiting

TMS for Inhibition Enhancement in Schizophrenia

Schizophrenia
NCT07746388 Phase 2
Recruiting

Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial

Nsclc
NCT05817370
Recruiting

Implementation of Anal Cancer Screening and Treatment in Nigeria

Education, Medical
NCT05948930
Recruiting

Working Memory and Physical Exercise Training in Patients With Mild Cognitive Impairment

Mild Cognitive Impairment
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology